Cargando…
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
The coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is caused when Spike-protein (S-protein) present on the surface of SARS-CoV-2 interacts with human cell surface receptor, Angiotensin-converting enzyme 2 (ACE2). This bind...
Autores principales: | Raghav, Pawan Kumar, Mann, Zoya, Ahluwalia, Simran Kaur, Rajalingam, Raja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930377/ https://www.ncbi.nlm.nih.gov/pubmed/37059487 http://dx.doi.org/10.1016/j.jphs.2023.02.004 |
Ejemplares similares
-
Hematopoietic Stem Cell Factors: Their Functional Role in Self-Renewal and Clinical Aspects
por: Mann, Zoya, et al.
Publicado: (2022) -
Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations
por: Raghav, Pawan Kumar, et al.
Publicado: (2023) -
A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
por: Ding, Xin, et al.
Publicado: (2020) -
Inclusion Complexes of Gold(I)‐Dithiocarbamates with β‐Cyclodextrin: A Journey from Drug Repurposing towards Drug Discovery
por: Morgen, Michael, et al.
Publicado: (2021) -
Repurposing FDA‐Approved Compounds for the Discovery of Glutaminyl Cyclase Inhibitors as Drugs Against Alzheimer's Disease
por: Xu, Chenshu, et al.
Publicado: (2020)